It increases the risk of diabetes, high blood pressure, heart disease, and joint problems
When taken as part of a structured weight loss program, semaglutide can help control food cravings, slow stomach emptying, and enhance insulin function, making it easier to maintain a calorie deficit for weight loss
Why this matters in 2026 specifically: the FDA declared the tirzepatide shortage resolved in 2025
This is an important distinction that affects both pricing and regulatory considerations, something we will cover in detail later
The most common side effects of the medication include: Nausea Vomiting Gastrointestinal issues Stomach pain Injection site reactions Thinning or hair loss Low blood pressure Indigestion and excessive burping Mild allergic response to the medication Sometimes, tirzepatide can cause severe side effects that need immediate medical attention